IDEX Biometrics ASA (0MTP)
London Stock Exchange · UK · prices in NOK · close of 27 Oct 2026
Key indicators
| Last close | NOK 7.680 |
|---|---|
| 52-week range | 2.950 – 12.300 |
| Return, 1 month / 3 months | +37.6% / −4.0% |
| Return, 1 year / 3 years | +156.0% / −92.2% |
| Trend | Uptrend |
| RSI (14) | 56 |
| Volatility (1 year) | 105.7% |
| Worst drawdown (1 year) | -55.7% |
| Average daily value traded | 0.04M NOK |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
IDEX Biometrics ASA develops fingerprint sensing and biometric authentication technology. The company supplies sensor solutions and related software that let cards, devices and access systems confirm a person's identity through a fingerprint. Its customers are mainly card manufacturers, device makers and identity solution providers that build biometric features into their products. IDEX Biometrics is based in Oslo, Norway, and works with partners and customers in several countries.
IDEX Biometrics ASA trades under the code 0MTP on the London Stock Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
IDEX Biometrics ASA (0MTP) trades on the London Stock Exchange in UK. It last closed at NOK 7.680 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,800 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 156.0% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 12.0% | ||
| From 52-week high | -37.0% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | -31.4% | ||
| 12-month return, skipping the last month | 86.0% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 105.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -55.7% | ||
| Liquidity | 22 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.04M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.4% |
|---|---|
| 1 month | +37.6% |
| 3 months | −4.0% |
| 6 months | −31.4% |
| 1 year | +156.0% |
| 3 years | −92.2% |
| 5 years | −98.8% |
Signals
| 50-day / 200-day average | 7.455 / 6.859 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.409 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.